DEA to begin requiring single-sheet form to order controlled substances
Health care providers registered with the Drug Enforcement Administration must use the new single-sheet form to order schedule I and II controlled substances, effective Oct. 30, the agency announced Monday. DEA began transitioning to the new form two years ago under a 2019 final rule. In July, DEA also published a direct final rule to clarify that either the purchaser or the supplier may enter a supplier’s DEA registration number on the new single-sheet form.
Related News Articles
Headline
The AHA July 13 commented on proposals by the Office of Management and Budget and other federal agencies to revise the Uniform Grants Regulation governing…
Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Headline
The AHA March 24 commented to the Centers for Medicare & Medicaid Services on upcoming requirements from the Consolidated Appropriations Act of 2026…
Headline
The AHA Feb. 27 shared recommendations on the Health Data, Technology and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity proposed rule,…
Headline
The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial…
Headline
The AHA and Federation of American Hospitals Aug. 8 filed an amicus brief in the U.S. District Court for the Eastern District of Texas in support of the U.S.…